Skip to main content
Industry News
Study links cognitive impairment to breast cancer

A study published in Psycho-Oncology found that from 21% to 25% of patients with breast cancer experienced cognitive impairment during and after treatment. Researchers reviewed 17 studies involving 1,978 breast cancer patients and found chemotherapy appeared to play a more significant role in cognitive dysfunction than radiotherapy and endocrine therapy.

Full Story: